Clinical research findings presented were from its comprehensive Myopia clinical research program with the Singapore Eye Research Institute (SERI) and Singapore National Eye Centre (SNEC).
At ARVO 2020, Johnson & Johnson Vision, together with SERI and SNEC, presented the first five studies from the group’s unique public-private strategic partnership. Since the start of the collaboration in April 2019, the group initiated nine research projects that include four clinical cohorts with 631 participants. The research projects are providing real-world evidence to better understand why Myopia develops, how it progresses, and how it might be intercepted by investigating underlying mechanisms.
“Johnson & Johnson Vision is focused on delivering innovation that meets major unmet needs,” said Song Xiao-Yu, MD, PhD, Global Head of Research and Development, Johnson & Johnson Vision Care, Inc.
“We are excited to present our first research at ARVO 2020 from our unique publicprivate Myopia strategic partnership that is working to address this growing epidemic. We will also share the latest findings on many investigational technologies, including our laser cataract surgery operating system.”
Other surgical innovations by were also presented by Johnson & Johnson Vision, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies at ARVO 2020. These include new data on CATALYS cOS 6.0 with Advanced Astigmatism Management and the new software for the CATALYS Precision Laser System.
It is estimated that by 2050, half of the world’s population is expected to be myopic, disproportionately affecting children. Johnson & Johnson Vision hopes to address this public health crisis by building a better understanding of the science and biology behind myopia and developing comprehensive programs to address and treat the disease.
The Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2020), was held as a virtual congress with Johnson & Johnson Vision author video presentations published on 15 June 2020. [APBN]